Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Wael Fayad currently holds 298,000 shares of Enumeral Biomedical Holdings, Inc. (ENUM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Wael Fayad has been a net neutral trader of ENUM stock. They have purchased $0 and sold $0 worth of shares.
Wael Fayad's most recent insider trade was on Dec 9, 2016, when they sold 298,000 shares at $0.13 per share.
Wael Fayad serves as Executive at Enumeral Biomedical Holdings, Inc. (ENUM). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Wael Fayad holds the position of Executive at Enumeral Biomedical Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Wael Fayad has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Wael Fayad was on Dec 9, 2016, when they sold $38.7K worth of ENUM shares. This transaction involved 298,000 shares at $0.13 per share.
Wael Fayad currently owns 298,000 shares of Enumeral Biomedical Holdings, Inc. (ENUM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Wael Fayad's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Wael Fayad has 1 Form 4 filings on record as an insider at Enumeral Biomedical Holdings, Inc..
Set alerts for Wael Fayad and 40,000+ other insiders.